# Orange Grove Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/orange-grove-bio

- Industry: Biotechnology
- Headquarters: Cincinnati, US
- Website: www.orangegrovebio.com/
- Total disclosed funding: $2M
- Latest round: Seed (Feb 23, 2021)
- Investors on record: 7

## About

Founded in 2019 and based in Michigan, US, Orange Grove Bio LLC operates as a developer of neutrophil treatments for diseases with dysregulation of immune signaling. The company was founded by Marc Appel. In October 2021, IpiNovyx Bio, Inc. raised USD 10 million in seed funding led by Viva BioInnovator, with participation from Alexandria Venture Investments, Eli Lilly & Company, Opaleye Management, Orange Grove Bio LLC, and Pathway Bioventures.

The company offers neutrophil targeting novel drug treatment for neutrophil-mediated diseases like Covid-19. The company also develops drugs in oncology, inflammatory, and autoimmune disease treatments, and different therapeutic modalities.

## Funding rounds

- Seed, Feb 23, 2021, $2M — Ann Arbor SPARK, Invest Detroit, Biosciences Research & Commercialization Center, ID Ventures, Red Cedar Ventures, Research Bridge Partners, Woodward Angels

## Investors

- Ann Arbor SPARK (https://capitalatlas.ai/funds/ann-arbor-spark) — Seed
- Invest Detroit (https://capitalatlas.ai/funds/invest-detroit) — Seed
- Biosciences Research & Commercialization Center (https://capitalatlas.ai/funds/biosciences-research-commercialization-center) — Seed
- ID Ventures (https://capitalatlas.ai/funds/id-ventures) — Seed
- Red Cedar Ventures (https://capitalatlas.ai/funds/red-cedar-ventures) — Seed
- Research Bridge Partners (https://capitalatlas.ai/funds/research-bridge-partners) — Seed
- Woodward Angels (https://capitalatlas.ai/funds/woodward-angels) — Seed